ArticleMedComm2025

Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Phase Ib Trial.

Qi-Xiang Rong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.